company background image
EO7 logo

Endo International DB:EO7 Stock Report

Last Price

€0.002

Market Cap

€108.6k

7D

-80.0%

1Y

-98.2%

Updated

26 Mar, 2024

Data

Company Financials

EO7 Stock Overview

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally.

EO7 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Endo International plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Endo International
Historical stock prices
Current Share PriceUS$0.002
52 Week HighUS$0.15
52 Week LowUS$0.0002
Beta0.86
1 Month Change-90.00%
3 Month Change-81.82%
1 Year Change-98.18%
3 Year Change-99.97%
5 Year Change-99.97%
Change since IPO-100.00%

Recent News & Updates

Recent updates

Shareholder Returns

EO7DE PharmaceuticalsDE Market
7D-80.0%2.1%1.6%
1Y-98.2%-26.3%6.4%

Return vs Industry: EO7 underperformed the German Pharmaceuticals industry which returned -26.3% over the past year.

Return vs Market: EO7 underperformed the German Market which returned 6.4% over the past year.

Price Volatility

Is EO7's price volatile compared to industry and market?
EO7 volatility
EO7 Average Weekly Movement215.8%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: EO7's share price has been volatile over the past 3 months.

Volatility Over Time: EO7's weekly volatility has increased from 129% to 216% over the past year.

About the Company

FoundedEmployeesCEOWebsite
19202,931Blaise Colemanhttps://www.endo.com

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The company offers branded pharmaceuticals, including XIAFLEX to treat adult patients with Dupuytren’s contracture and Peyronie’s disease; SUPPRELIN LA to treat central precocious puberty in children; AVEED to treat hypogonadism; NASCOBAL nasal spray to treat vitamin B12 deficiency; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET for pain management; TESTOPEL, an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; and EDEX to treat erectile dysfunction, as well as opioid products to treat pain associated with post-herpetic neuralgia.

Endo International plc Fundamentals Summary

How do Endo International's earnings and revenue compare to its market cap?
EO7 fundamental statistics
Market cap€108.59k
Earnings (TTM)-€2.26b
Revenue (TTM)€1.86b

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EO7 income statement (TTM)
RevenueUS$2.01b
Cost of RevenueUS$941.90m
Gross ProfitUS$1.07b
Other ExpensesUS$3.52b
Earnings-US$2.45b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-10.41
Gross Margin53.17%
Net Profit Margin-121.69%
Debt/Equity Ratio-123.5%

How did EO7 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.